Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

Watson acquires Searle contraceptive products

Oct. 27, 1997

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

Major advance in thalassemia research reported

Oct. 24, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Viagra awarded priority review status by FDA

Oct. 23, 1997

Role of angiotensin II in erectile function investigated

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

rhIGF-1 improves lipid profiles in adults with IDDM

Oct. 23, 1997

Ligand and Lilly enter drug discovery and development alliance for metabolic drugs

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...